AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
+12.54%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$1.72B
AUM Growth
+$1.72B
(-6.8%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-13.17%
Top 10 Holdings %
Top 10 Hldgs %
92.89%
Holding
42
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
GitLab
GTLB
|
$207M |
| 2 |
Snowflake
SNOW
|
$13.2M |
| 3 |
Revolution Medicines
RVMD
|
$5.38M |
| 4 |
RAPT Therapeutics
RAPT
|
$1.09M |
Sector Composition
| 1 | Technology | 63.06% |
| 2 | Healthcare | 29.23% |
| 3 | Industrials | 7.66% |
| 4 | Consumer Staples | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GitLab
GTLB
$7.93B
| $343M | 19.98% | 6,091,238 -3,667,095 | -38% | -$207M |
|
2
Freshworks
FRSH
$3.93B
| $262M | 15.26% | 16,206,643 | – | – |
|
3
Arm
ARM
$147B
| $242M | 14.08% | 1,960,784 | – | – |
|
|
4
Revolution Medicines
RVMD
$7.1B
| $181M | 10.53% | 4,133,277 -122,898 | -3% | -$5.38M |
|
5
CrowdStrike
CRWD
$106B
| $146M | 8.52% | 427,895 | – | – |
|
6
Planet Labs
PL
$2.15B
| $129M | 7.51% | 31,942,641 | – | – |
|
7
UiPath
PATH
$5.95B
| $89.4M | 5.21% | 7,034,337 | – | – |
|
8
DexCom
DXCM
$29.5B
| $80.6M | 4.69% | 1,036,937 | – | – |
|
|
VERV
9
DELISTED
Verve Therapeutics
VERV
| $69.6M | 4.06% | 12,349,086 | – | – |
|
|
TEM
10
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $52.4M | 3.05% | 1,551,102 | – | – |
|
11
Prime Medicine
PRME
$578M
| $44M | 2.56% | 15,062,498 | – | – |
|
12
Vera Therapeutics
VERA
$1.38B
| $10.2M | 0.59% | 241,264 | – | – |
|
13
Monte Rosa Therapeutics
GLUE
$296M
| $10.2M | 0.59% | 1,464,015 | – | – |
|
14
Beam Therapeutics
BEAM
$1.66B
| $7.98M | 0.46% | 321,604 | – | – |
|
15
Oscar Health
OSCR
$4.31B
| $6.48M | 0.38% | 481,988 | – | – |
|
16
Relay Therapeutics
RLAY
$619M
| $6.46M | 0.38% | 1,568,753 | – | – |
|
17
Sana Biotechnology
SANA
$777M
| $4.58M | 0.27% | 2,812,500 | – | – |
|
18
Dianthus Therapeutics
DNTH
$759M
| $4.55M | 0.26% | 208,697 | – | – |
|
19
Lyell Immunopharma
LYEL
$213M
| $3.75M | 0.22% | 5,865,125 | – | – |
|
20
TScan Therapeutics
TCRX
$102M
| $3.27M | 0.19% | 1,077,080 | – | – |
|
|
DM
21
DELISTED
Desktop Metal, Inc.
DM
| $2.59M | 0.15% | 1,104,871 | – | – |
|
22
Foghorn Therapeutics
FHTX
$286M
| $2.36M | 0.14% | 500,901 | – | – |
|
|
BRNS
23
Barinthus Biotherapeutics
BRNS
$45.6M
| $1.83M | 0.11% | 1,513,644 | – | – |
|
24
GeneDx Holdings
WGS
$3.72B
| $1.75M | 0.1% | 22,711 | – | – |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$399M
| $1.64M | 0.1% | 698,262 | – | – |
|